The Ketek antibiotic drug which is used for treating lung and sinus infections has been found to cause liver failure, according to a report. Medical practitioners belonging to the Carolinas Medical Center said that they found three cases of liver failure in patients to whom the drug had been administered, according to the Annals of Internal Medicine.
All three cases occurred within a few months of each other last year, said report co-author John Hanson, a liver transplant doctor at the medical center. 'Ketek' is prescribed to treat lung and sinus infections. The antibiotic also led to the death of a 26-year-old man and transplant surgery for a 51-year-old woman.
Ketek was approved by the US Food and Drug Administration in 2004. Doctors have sent their findings to the FDA and discussed them with Sanofi-Aventis SA, which makes Ketek. The company is currently reviewing the data, the report said.